Royal Bank Of Canada Olink Holding Ab (Publ) Transaction History

Royal Bank Of Canada

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$21.87 - $25.59 $130,826 - $153,079	-5,982 Reduced 99.15%	51 $1,000
Q1 2024 Nov 05, 2024	BUY	$21.81 - $25.14 $130,467 - $150,387	5,982 Added 11729.41%	6,033 $141,000
Q1 2024 May 15, 2024	BUY	$21.81 - $25.14 $130,990 - $150,990	6,006 Added 22244.44%	6,033 $141,000
Q4 2023 Feb 14, 2024	BUY	$14.29 - $25.95 $214 - $389	15 Added 125.0%	27 $0
Q3 2023 Nov 14, 2023	SELL	$14.45 - $20.34 $3,930 - $5,532	-272 Reduced 95.77%	12 $0
Q2 2023 Aug 14, 2023	BUY	$17.13 - $23.74 $2,089 - $2,896	122 Added 75.31%	284 $5,000
Q1 2023 May 15, 2023	BUY	$19.34 - $24.11 $3,036 - $3,785	157 Added 3140.0%	162 $3,000
Q4 2022 Feb 14, 2023	SELL	$12.64 - $25.52 $1,504 - $3,036	-119 Reduced 95.97%	5 $0
Q3 2022 Nov 14, 2022	BUY	$12.14 - $18.42 $1,493 - $2,265	123 Added 12300.0%	124 $1,000
Q2 2022 Aug 15, 2022	BUY	$8.95 - $19.24 $8 - $19	1 New	1 $0

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.